fetal tissue research

Dear Research Advocate, Anticipation is building for the Research!America 2020 Virtual #RAForum: Straight Talk: Securing a Science-Strong Future , featuring federal officials, members of Congress from both sides of the aisle, and other leaders from across the R&D and public health ecosystem to explore the intersection of public and private sector-driven science and pandemic response, recovery, and preparedness. An important late-breaking addition to the Forum program is HHS Secretary Alex M. Azar II, who will be in conversation with journalist and Research!America board member Susan Dentzer. We are also excited to let you know ADM Brett P. Giroir, MD, the Assistant Secretary for Health...
Dear Research Advocate, On Capitol Hill : Senate Republicans have a new legislative proposal for COVID-19 emergency supplemental spending which includes provisions such as extended unemployment benefits and emergency funding for USPS, but no supplemental funding to restore COVID-19-eroded research dollars. Speaking up now is essential if there is to be an emergency spending bill that fully fights back COVID-19’s attack on the nation’s economy and health security. Reach out to your members of Congress to encourage them to include at least $26 billion in funding to restart lifesaving research supported by our health and science agencies. Here are two ways you can act right away: send this...
Dear Research Advocate, We lost two extraordinary Civil Rights heroes this past weekend, John Lewis and C.T. Vivian. Of these courageous, committed advocates, Dr. Louis Sullivan, former HHS Secretary, Research!America emeritus board member, and friend to research advocacy, said in a statement: “ The lives of millions are better today because of their leadership and their sacrifice .” AAAS has begun a “transition to a lifelong commitment of actions to eradicate anti-Black racism in academia and STEM.” AAAS CEO and Research!America board member Dr. Sudip Parikh is leading the three-phase effort. You can review the first phase of the draft plan now. AAAS welcomes your feedback; please email...
Dear Research Advocate, Research!America board member and APHA Executive Director Dr. Georges Benjamin addressed a recent alliance meeting, discussing three epidemics: COVID-19: Emerging infectious disease; Infodemic: Misinformation and disinformation; and Epidemic of Fear: Fear of the unknown, complicated by misstatements and poor risk communication by a range of actors in a rapidly moving communication environment. Dr. Benjamin emphasized the importance of correcting misinformation – not letting bad information go unchecked. He also suggested we talk about “physical” distancing rather than “social” distancing because being social is important to our health and well-being and shouldn’t be...
Dear Research Advocate, Partnering with the National Disease Research Interchange (NDRI), Research!America commissioned a survey released this week finding that not only do Americans strongly support organ and tissue donation for research, they believe it is important to encourage more people to donate for both medical and research purposes. Respondents admire those who donate for research as well as for transplant. We may be at an important inflection point with more research made possible because more people will donate. Speaking of surveys, the AAAS Annual Meeting last week was jam-packed with programs about how the public trusts (or mostly trusts) science and appreciates scientific...
Dear Research Advocate, Last summer, the administration announced a new policy targeting fetal tissue research. The Washington Post reported this week on the troubling consequences for scientists, scientific progress, and thus patients. Research!America stood with patients and researchers against this retrograde policy change when it was first contemplated and, as part of a coalition led by the International Society for Stem Cell Research (ISCCR), we continue to push back. (It’s well to remember that fetal tissue research is not only playing a significant role today in research for vaccine development, Down syndrome, MS, and Parkinson’s, but its untapped potential holds significance for...
Dear Research Advocate, Our guest author this week is Jenny Luray, Research!America’s Senior Advisor. Before traveling home for the August district work period, the House finally passed legislation to raise the budget caps by a vote of 284 - 149. Monday evening brought the welcome announcement that the White House and congressional leadership had reached a bipartisan, bicameral budget deal . The deal lifts the caps, increasing federal spending levels in FY2020 and FY2021, and also raises the debt ceiling. Specifically, the deal increases non-defense discretionary spending by $27 billion in FY20 and $2.5 billion in FY21. It prevents a $55 billion cut from occurring and instead bolsters the...
Dear Research Advocate, The House is working to reach its goal of passing all twelve FY20 appropriations bills by the end of June, debating a “minibus” package of four of those bills this week, including the Labor, HHS, and Education funding bill that includes funding for the Centers for Disease Control (CDC), National Institutes of Health (NIH), and the Agency for Healthcare Research and Quality (AHRQ). Next week, a second “minibus” package of appropriations bills will be on the House Floor, including funding for the National Science Foundation (NSF) and Food and Drug Administration (FDA). (As time goes on without a budget cap resolution, it remains critical to do your part to assure a...
Dear Research Advocate, In a recent weekly letter, I mentioned that advocacy in support of fetal tissue research continued to be critical, despite the apparent lull in an Administration effort to evaluate how to curtail/replace this avenue of research. Apparent is the operative word. Yesterday, the Administration announced that an NIH fetal tissue research-related contract with UCSF will not be renewed; intramural researchers at NIH will no longer be able to procure fetal tissue for research; and another layer of review will be imposed on all those seeking federal funding for fetal tissue research. Read our statement , an Axios article, and, most importantly, contact Eric Anthony ( eanthony...
Dear Research Advocate: Research!America had the opportunity this week to attend a Senate NIH Caucus meeting featuring Dr. Jennifer Doudna, the world-renowned biochemist at UC Berkeley, who is a pioneer in the field of gene editing. A big thank you to Jed Manocherian and ACT for NIH for working with Senator Dick Durbin (D-IL) to bring Dr. Doudna to Capitol Hill to discuss the powerful new technology known as CRISPR, which has potentially curative applications for diseases such as sickle cell and cancer. Here is a list of current Senate NIH Caucus members. Take a moment to send your Senators an email urging them to join if they are not already members. Congress has just six days to act...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor